BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ergul Y, Ekici B, Nisli K, Tatli B, Binboga F, Acar G, Ozmen M, Omeroglu RE. Evaluation of the North Star Ambulatory Assessment scale and cardiac abnormalities in ambulant boys with Duchenne muscular dystrophy. J Paediatr Child Health. 2012;48:610-616. [PMID: 22404693 DOI: 10.1111/j.1440-1754.2012.02428.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Meyers TA, Heitzman JA, Krebsbach AM, Aufdembrink LM, Hughes R, Bartolomucci A, Townsend D. Acute AT1R blockade prevents isoproterenol-induced injury in mdx hearts. J Mol Cell Cardiol 2019;128:51-61. [PMID: 30664850 DOI: 10.1016/j.yjmcc.2019.01.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
2 Yoo WH, Cho MJ, Chun P, Kim KH, Lee JS, Shin YB. The evolution of electrocardiographic changes in patients with Duchenne muscular dystrophies. Korean J Pediatr 2017;60:196-201. [PMID: 28690647 DOI: 10.3345/kjp.2017.60.6.196] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
3 Jeanson-leh L, Lameth J, Krimi S, Buisset J, Amor F, Le Guiner C, Barthélémy I, Servais L, Blot S, Voit T, Israeli D. Serum Profiling Identifies Novel Muscle miRNA and Cardiomyopathy-Related miRNA Biomarkers in Golden Retriever Muscular Dystrophy Dogs and Duchenne Muscular Dystrophy Patients. The American Journal of Pathology 2014;184:2885-98. [DOI: 10.1016/j.ajpath.2014.07.021] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 8.4] [Reference Citation Analysis]
4 Guo LJ, Soslow JH, Bettis AK, Nghiem PP, Cummings KJ, Lenox MW, Miller MW, Kornegay JN, Spurney CF. Natural History of Cardiomyopathy in Adult Dogs With Golden Retriever Muscular Dystrophy. J Am Heart Assoc 2019;8:e012443. [PMID: 31411085 DOI: 10.1161/JAHA.119.012443] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
5 Posner AD, Soslow JH, Burnette WB, Bian A, Shintani A, Sawyer DB, Markham LW. The Correlation of Skeletal and Cardiac Muscle Dysfunction in Duchenne Muscular Dystrophy. J Neuromuscul Dis 2016;3:91-9. [PMID: 27182492 DOI: 10.3233/JND-150132] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
6 Schmid J, Liesinger L, Birner-Gruenberger R, Stojakovic T, Scharnagl H, Dieplinger B, Asslaber M, Radl R, Beer M, Polacin M, Mair J, Szolar D, Berghold A, Quasthoff S, Binder JS, Rainer PP. Elevated Cardiac Troponin T in Patients With Skeletal Myopathies. J Am Coll Cardiol. 2018;71:1540-1549. [PMID: 29622161 DOI: 10.1016/j.jacc.2018.01.070] [Cited by in Crossref: 62] [Cited by in F6Publishing: 44] [Article Influence: 31.0] [Reference Citation Analysis]
7 Signorelli M, Ayoglu B, Johansson C, Lochmüller H, Straub V, Muntoni F, Niks E, Tsonaka R, Persson A, Aartsma-Rus A, Nilsson P, Al-Khalili Szigyarto C, Spitali P. Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy. J Cachexia Sarcopenia Muscle 2020;11:505-17. [PMID: 31881125 DOI: 10.1002/jcsm.12517] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
8 Koenig X, Ebner J, Hilber K. Voltage-Dependent Sarcolemmal Ion Channel Abnormalities in the Dystrophin-Deficient Heart. Int J Mol Sci 2018;19:E3296. [PMID: 30360568 DOI: 10.3390/ijms19113296] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
9 Allegaert K. Clinical pharmacological studies in children: From exploratory towards confirmation driven methodology. World J Clin Pediatr. 2012;1:3-7. [PMID: 25254160 DOI: 10.5409/wjcp.v1.i2.3] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
10 Meyers TA, Townsend D. Cardiac Pathophysiology and the Future of Cardiac Therapies in Duchenne Muscular Dystrophy. Int J Mol Sci 2019;20:E4098. [PMID: 31443395 DOI: 10.3390/ijms20174098] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 22.0] [Reference Citation Analysis]